Skip to content

Comparison of the effects of Corticosteroid injection, PRP injection, and incubated PRP injection on improving pain and range of motion in patients with partial thickness rotator cuff tears referred to clinics in Kerman in 2025.

Comparison of the effects of Corticosteroid injection, PRP injection, and incubated PRP injection on improving pain and range of motion in patients with partial thickness rotator cuff tears referred to clinics in Kerman in 2025.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260106068578N1
Enrollment
150
Registered
2026-05-09
Start date
2026-05-09
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

partial thickness rotator cuff tears.

Interventions

Intervention 1: Intervention group: Intervention group: PRP injection. Injection of the therapeutic combination into the subacromial space is performed for two consecutive periods at 3-week intervals.

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 40 to 70 years. 2. Clinically and radiographically diagnosed partial-thickness tear of the supraspinatus tendon, involving less than 50% of the total tendon thickness. 3. Ellman grade I or II. 4. First-time diagnosis within the last 6 months. 5. Absence of tendon retraction exceeding 1 cm. 6. No history of subacromial corticosteroid or PRP injection within the last 6 months. 7. No systemic corticosteroid use within the last 3 months.

Exclusion criteria

Exclusion criteria: 1. Pregnancy. 2. Age over 70 years. 3. Rotator cuff tear secondary to trauma or fracture. 4. Active infection in the shoulder or systemic infection. 5. Previous history of shoulder surgery or arthroscopy. 6. Uncontrolled diabetes (HbA1c > 8.5%). 7. Hematologic disorders (e.g., hemophilia, thrombocytopenia, or platelet disorders). 8. Substance or alcohol abuse. 9. Systemic inflammatory diseases (e.g., active rheumatoid arthritis). 10. Shoulder pain of non-rotator cuff origin (e.g., cervical or neurological disorders). 11. Non-compliance with the treatment protocol or loss to follow-up during the study.

Design outcomes

Primary

MeasureTime frame
Pain score and range of motion in patients with partial rotator cuff tears. Timepoint: Pain scores and range of motion of patients with incomplete rotator cuff tears are measured before and 6 months after the intervention. Method of measurement: To assess the level of pain, a visual analogue scale (VAS) is used, ranging from 0, indicating no pain, to 10, indicating severe pain. The American Shoulder and Elbow Surgeons (ASES) questionnaire, which has items to assess pain and instability and 10 items to assess the patient's ability to perform activities of daily living (ADL), is used. In addition, a constant score is used to assess the range of motion and strength of the affected shoulder.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Amireza Sadeghifar

Kerman University of Medical Sciences

sobhan.mohammadi.hd@gmail.com+98 34 3281 1217

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026